Related Experiment Video
Updated: Jan 27, 2026
08:55
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
18.8K
Natriuretic Peptides in Clinical Practice.
Yüksel Çavuşoğlu1, Ahmet Taha Alper, Hakan Altay
1Department of Cardiology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir-Turkey. yukselc@ogu.edu.tr.
Anatolian Journal of Cardiology
|March 13, 2019
Summary
Natriuretic peptides are crucial biomarkers for heart failure diagnosis and prognosis. Despite limitations, they remain essential in clinical practice and show potential in various other cardiovascular conditions.
Area of Science:
- Cardiology
- Biomarker Research
- Clinical Practice
Background:
- Natriuretic peptides are established biomarkers in clinical practice.
- They offer valuable insights into heart failure diagnosis, prognosis, and risk stratification.
- Despite limitations like specificity issues, they are the most utilized heart failure biomarkers.
Purpose of the Study:
- To review updated information and new recommendations for natriuretic peptides in heart failure.
- To explore the potential roles of natriuretic peptides in managing diverse clinical conditions.
- To provide expert opinion based on current literature regarding natriuretic peptide utility.
Main Methods:
- Literature review of natriuretic peptides in heart failure.
- Analysis of current guidelines and expert opinions.
- Synthesis of data on natriuretic peptide applications in various cardiovascular diseases.
Main Results:
- Natriuretic peptides are recognized as essential tools in current heart failure guidelines.
- They play a role in diagnosis, prognosis, risk stratification, and therapy guidance for heart failure.
- Emerging evidence suggests potential applications in primary prevention, cardio-oncology, and other cardiovascular conditions.
Conclusions:
- Natriuretic peptides are indispensable in contemporary heart failure management.
- Their utility extends beyond heart failure, with promising roles in broader cardiovascular medicine.
- Continued research and updated recommendations will further refine their clinical application.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
574
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
574
02:43Peptide Bonds
82.7K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.7K
01:16Characteristics of Practical Op Amps
856
A difference amplifier, a crucial component in numerous electronic devices, ideally amplifies only the difference-mode signal, which is the difference between two input signals. However, in practical circuits, the output voltage depends on both the differential gain and the common-mode gain.
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
856
01:30Theoretical Foundations of Nursing Practice
17.4K
Theories play an essential role in organizing patient care. Theories refer to a proposed or followed belief, policy, or procedure that is the basis for action. Nursing theories are knowledge-based concepts that guide nurses' actions, influence nursing education and practice, and allow nurses to care for their patients.
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
17.4K
01:28Equivalent Circuits for Practical Transformers
1.4K
The practical equivalent circuits of single-phase two-winding transformers exhibit significant deviations from their idealized versions due to the inherent properties of winding resistance and finite core permeability. These properties result in real and reactive power losses, affecting the transformer's performance. Understanding these deviations is crucial for designing more efficient transformers.
In a practical transformer, each winding exhibits resistance and leakage reactance. The...
In a practical transformer, each winding exhibits resistance and leakage reactance. The...
1.4K
01:16Clinical Trials
10.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.3K